Could a plant extract help calm delirium? first human trial begins

NCT ID NCT07422142

Not yet recruiting Symptom relief Sponsor: Kunming Pharmaceuticals, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early-stage study will test whether an injection of gastrodin, a compound from a traditional Chinese herb, is safe and tolerable in 54 healthy adults. Researchers will also measure how the drug moves through the body. If successful, this could lead to larger studies in patients with delirium, a sudden confused state often seen in hospital settings.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: gastrodin injection
What this could lead to: If this early safety study succeeds, it could pave the way for a new treatment to ease delirium symptoms in hospitalized patients.
What could go wrong: This is a very early Phase 1 trial in only 54 healthy people, not patients with delirium. It tests safety, not effectiveness, so it may not lead to a working treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DELIRIUM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

delirium

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DELIRIUM

Contacts and locations

Locations

The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine

Tianjin, Tianjin Municipality, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.